Keyphrases
Lung Cancer
100%
Non-small Cell Lung Cancer (NSCLC)
52%
Japan
51%
Sirtuin 1 (SIRT1)
41%
Prognostic Factors
34%
Monotherapy
33%
Afatinib
31%
C-Jun N-terminal Kinase Signaling
31%
SRT1720
31%
Small Cell Lung Cancer
31%
Elderly Patients
31%
Point-of-care Ultrasound (POCUS)
31%
Progression-free Survival
29%
Lung Adenocarcinoma
28%
Body Mass Index
24%
Ultrasound Examination
23%
Thickening Fraction
23%
MRNA Level
23%
Asthma
22%
Clinical Course
22%
Dyspnea
22%
Lactate Dehydrogenase
21%
EGFR-mutant Lung Cancer
21%
Older Men
21%
Young Patients
20%
Performance Status
19%
Adverse Effects
19%
Appetite Loss
19%
Ischemic Heart Disease
18%
Training Course
18%
Trauma
18%
EGFR Status
17%
Leptomeningeal Carcinomatosis
17%
Gefitinib
17%
Lung
16%
General Medicine
16%
Mouse Model of Asthma
15%
Total Adiponectin
15%
Multiple Mini-interview
15%
Medical Admissions
15%
Maintenance Treatment
15%
Regulated on Activation
15%
Hepatitis C Virus Antibodies
15%
Job Description
15%
Large-scale Observational Study
15%
Bioelectrical Impedance Analysis
15%
Novice Learners
15%
Chronic Obstructive Pulmonary Disease Patient
15%
PD-1 Inhibitor
15%
Esophageal Hematoma
15%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
53%
Non Small Cell Lung Cancer
50%
Small Cell Lung Cancer
47%
Retrospective Study
43%
Lung Cancer
43%
Progression Free Survival
35%
Messenger RNA
34%
Phosphotransferase
31%
N [2 [3 (1 piperazinylmethyl)imidazo[2,1 B]thiazol 6 Yl]phenyl] 2 Quinoxalinecarboxamide
31%
Chemotherapy
28%
Monotherapy
28%
Asthma
27%
Adverse Event
26%
Lactate Dehydrogenase
23%
Inflammation
19%
Cytokine
18%
Neoplasm
17%
Squamous Cell Lung Carcinoma
15%
Afatinib
15%
Disease Course
15%
Acute Hepatitis C
15%
Multidrug Resistance Associated Protein 1
15%
Isoprenaline
15%
Doxorubicin
15%
Chronic Obstructive Lung Disease
15%
Recurrent Disease
15%
Mouse Model
15%
Ovalbumin
15%
Wheezing
15%
Hepatitis C Virus
15%
Sirtuin 1
15%
Protein P53
15%
Ionizing Radiation
15%
Cohort Study
15%
Group Trial
15%
Loss of Appetite
15%
Hydrocortisone
15%
Pemetrexed
15%
Radiation Pneumonia
15%
Deterioration
15%
Amrubicin
15%
Ischemic Heart Disease
15%
Lung Metastasis
15%
Breast Cancer
15%
Phosphatase
15%
Disease
15%
Overall Survival
13%
Fibrosis
13%
Docetaxel
12%
Minoxidil
11%
Medicine and Dentistry
Lung Cancer
94%
Retrospective Study
42%
Small Cell Lung Cancer
36%
Non Small Cell Lung Cancer
31%
Sirtuin1
31%
Point-of-Care Ultrasound
31%
Lung Adenocarcinoma
28%
Epidermal Growth Factor Receptor
25%
Dyspnea
24%
Diaphragm
23%
Disease
23%
Disease Course
22%
Adverse Event
21%
Lung
21%
Body Mass Index
20%
Amino Terminal Sequence
19%
Loss of Appetite
19%
Outpatient
18%
Tumor Cell
18%
Injury
18%
Monotherapy
17%
Messenger RNA
17%
Cross Sectional Study
17%
Gefitinib
17%
Meningeal Carcinomatosis
17%
Local Therapy
15%
Hamartoma
15%
Acute Hepatitis C
15%
Multidrug Resistance Associated Protein 1
15%
Pneumocystis Pneumonia
15%
Systemic Therapy
15%
Lung Cancer Cell Line
15%
Recurrent Disease
15%
Doxorubicin
15%
Phosphotransferase
15%
Hydrocortisone
15%
Cartilage Fracture
15%
Hepatitis C Virus
15%
Amrubicin
15%
Mesothelioma
15%
Sarcomatoid Carcinoma
15%
Lung Aspergillosis
15%
Chronic Obstructive Pulmonary Disease
15%
Afatinib
15%
Hematoma
15%
Physical Activity
15%
Triage
15%
Rapid Response Team
15%
Peripheral Blood Mononuclear Cell
15%
Esophagus
15%
